查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1606696

糖尿病診斷市場：按糖尿病類型、產品類型、糖尿病診斷類型、最終用戶分類 - 全球預測 2025-2030

Diabetes Diagnostics Market by Diabetes Type (Diabetes I, Diabetes II, Gestational Diabetes), Product (Biochips, Glucose Monitors, Kits), Diabetes Diagnostics Type, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年糖尿病診斷市值為203.7億美元，預計2024年將達到219.1億美元，複合年成長率為7.80%，到2030年將達到344.8億美元。

糖尿病診斷市場包括各種用於識別和監測糖尿病的設備和技術。這包括 HbA1c檢測套組，以及新興技術，例如連續攜帶式血糖監測設備和非侵入性血糖監測方法。這些診斷的需求源於全球糖尿病盛行率的不斷上升，受生活方式因素和老化等人口變化的影響。其用途廣泛，包括個人用於糖尿病管理、臨床實驗室用於診斷和監測以及糖尿病治療進展的研究。最終用途主要取決於診斷中心、醫院和家庭醫療保健機構。

主要市場統計
基準年[2023] 203.7億美元
預測年份 [2024] 219.1億美元
預測年份 [2030] 344.8億美元
複合年成長率（%） 7.80%

該市場的關鍵成長要素包括技術進步、醫療保健意識的提高以及向預防醫學的轉變。數位健康的進步，例如將人工智慧整合到糖尿病管理中以實現個人化治療計劃和預測分析，帶來了巨大的成長機會。值得注意的機會包括開發可提高患者舒適度和依從性的非侵入性和微創診斷工具。對公司的建議包括投資創新診斷的研發、增加進入新興市場的機會以及建立技術整合的策略夥伴關係。

挑戰包括新設備核准的監管障礙、與先進診斷工具相關的高成本以及不同的地區報銷政策。解決這些限制需要齊心協力簡化產品核可流程並倡導標準化報銷通訊協定。

感測器技術、資料整合和即時監測系統領域存在大量創新機會，以實現更全面的糖尿病管理。在持續的技術進步和對精準醫療日益重視的推動下，市場仍然充滿活力。公司可以利用這些見解，透過專注於協作開發並確保適應不斷變化的法規環境和新興市場需求，確保永續成長。

市場動態：快速發展的糖尿病診斷市場的關鍵市場洞察

供需的動態交互作用正在改變糖尿病診斷市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 隨著老年人口的增加，糖尿病盛行率不斷上升
    • 家庭自我監測血糖值的成長趨勢
    • 政府針對糖尿病的措施和公共衛生宣傳活動
  • 市場限制因素
    • 糖尿病診斷設備高成本
  • 市場機會
    • 更多採用就地檢驗設備
    • 將糖尿病診斷與數位健康平台連接起來的技術持續進步
  • 市場挑戰
    • 糖尿病診斷設備的設備精確度與校準問題

波特五力：駕馭糖尿病診斷市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解外部對糖尿病診斷市場的影響

外部宏觀環境因素在塑造糖尿病診斷市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解糖尿病診斷市場的競爭狀況

對糖尿病診斷市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣糖尿病診斷市場供應商績效評估

FPNV 定位矩陣是評估糖尿病診斷市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，描繪糖尿病診斷市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對糖尿病診斷市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5.產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 隨著人口老化的加劇，糖尿病的發生率也隨之增加
      • 在家自我監測血糖值的趨勢正在增加。
      • 解決糖尿病問題的政府措施和公共衛生宣傳活動
    • 抑制因素
      • 糖尿病診斷設備高成本
    • 機會
      • 增加就地檢驗設備的引進
      • 糖尿病診斷和與數位健康平台連接的技術不斷進步
    • 任務
      • 糖尿病診斷設備的準確性與校準問題
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章以糖尿病類型分類的糖尿病診斷藥物市場

  • Ⅰ型糖尿病
  • 第二型糖尿病
  • 妊娠糖尿病

第7章糖尿病診斷市場：按產品

  • 生物晶片
  • 血糖值監測儀
  • 套件
  • 採血針

第8章以糖尿病診斷藥物類型分類的糖尿病診斷藥物市場

  • 血糖值測試
  • 空腹血糖值測試
  • 醣化血紅素(A1C) 測試
  • 口服葡萄糖耐受試驗（OGTT）

第9章糖尿病診斷市場：依最終使用者分類

  • 診斷中心
  • 家庭護理設置
  • 醫院

第10章北美和南美糖尿病診斷藥物市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太地區糖尿病診斷市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲糖尿病診斷藥物市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • 3M Company
  • Abbott Laboratories
  • Acon Laboratories, Inc.
  • AgaMatrix, Inc.
  • Apex Biotechnology Corporation
  • ARKRAY, Inc.
  • B. Braun Melsungen AG
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Diabetomics, Inc.
  • Diazyme Laboratories Inc
  • F. Hoffmann-La Roche Ltd.
  • ICON PLC
  • Medtronic PLC
  • Menarini Group
  • Nova Biomedical Corporation
  • Prestige Diagnostics
  • Sanwa Kagaku Kenkyusho Co, Ltd.
  • Siemens Healthineers AG
  • Sinocare, Inc.
  • Terumo Corporation
  • Tosoh Bioscience, Inc.
  • Trinity Biotech PLC
Product Code: MRR-2A0283E25680

The Diabetes Diagnostics Market was valued at USD 20.37 billion in 2023, expected to reach USD 21.91 billion in 2024, and is projected to grow at a CAGR of 7.80%, to USD 34.48 billion by 2030.

The diabetes diagnostics market encompasses a wide range of devices and technologies used to identify and monitor diabetes. This includes glucose monitoring devices, both continuous and portable, as well as HbA1c testing kits, and newly emerging technologies like non-invasive glucose monitoring methods. The necessity of these diagnostics stems from the increasing global incidence of diabetes influenced by lifestyle factors and demographic changes, including aging populations. Applications are vast, including personal use for diabetes management, clinical laboratory use for diagnosis and monitoring, and research concerning diabetes treatment advancements. End-use primarily varies between diagnostic centers, hospitals, and home healthcare settings.

KEY MARKET STATISTICS
Base Year [2023] USD 20.37 billion
Estimated Year [2024] USD 21.91 billion
Forecast Year [2030] USD 34.48 billion
CAGR (%) 7.80%

Key growth influencers in this market include advancements in technology, increasing healthcare awareness, and a shift toward preventive healthcare. Digital health advancements, such as the integration of AI in diabetes management for personalized treatment plans and predictive analytics, present substantial growth opportunities. Noteworthy opportunities include the development of non-invasive and minimally invasive diagnostic tools which cater to patient comfort and compliance. Recommendations for businesses include investing in R&D for innovative diagnostic methods, expanding access to emerging markets, and forming strategic partnerships for technology integration.

Challenges include regulatory hurdles for new device approvals, high costs associated with advanced diagnostic tools, and variable reimbursement policies across regions. Addressing these limitations requires concerted efforts in streamlining the product approval process and advocating for standardized reimbursement protocols.

Innovation opportunities are rich in the areas of sensor technology, data integration, and real-time monitoring systems, enabling more comprehensive diabetes management. The market remains dynamic, driven by continuous technological progress and a growing emphasis on precision medicine. Businesses can leverage these insights by focusing on collaborative developments and ensuring adaptability to changing regulatory environments and emerging market demands, thus ensuring sustainable growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Diabetes Diagnostics Market

The Diabetes Diagnostics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of diabetes with increasing geriatric population
    • Increasing trend of self-monitoring blood glucose levels at home
    • Government initiatives and public health campaigns to address diabetes
  • Market Restraints
    • High cost of diabetes diagnostic devices
  • Market Opportunities
    • Increasing adoption of point-of-care testing devices
    • Ongoing technological advancements in diabetes diagnostics and connectivity with digital health platforms
  • Market Challenges
    • Device accuracy and calibration issues with diabetes diagnostic device

Porter's Five Forces: A Strategic Tool for Navigating the Diabetes Diagnostics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Diabetes Diagnostics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Diabetes Diagnostics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Diabetes Diagnostics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Diabetes Diagnostics Market

A detailed market share analysis in the Diabetes Diagnostics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Diabetes Diagnostics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Diabetes Diagnostics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Diabetes Diagnostics Market

A strategic analysis of the Diabetes Diagnostics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Diabetes Diagnostics Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, Acon Laboratories, Inc., AgaMatrix, Inc., Apex Biotechnology Corporation, ARKRAY, Inc., B. Braun Melsungen AG, Beckman Coulter, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Danaher Corporation, Diabetomics, Inc., Diazyme Laboratories Inc, F. Hoffmann-La Roche Ltd., ICON PLC, Medtronic PLC, Menarini Group, Nova Biomedical Corporation, Prestige Diagnostics, Sanwa Kagaku Kenkyusho Co, Ltd., Siemens Healthineers AG, Sinocare, Inc., Terumo Corporation, Tosoh Bioscience, Inc., and Trinity Biotech PLC.

Market Segmentation & Coverage

This research report categorizes the Diabetes Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Diabetes Type, market is studied across Diabetes I, Diabetes II, and Gestational Diabetes.
  • Based on Product, market is studied across Biochips, Glucose Monitors, Kits, and Lancets.
  • Based on Diabetes Diagnostics Type, market is studied across Blood Glucose Test, Fasting Plasma Glucose Test, Glycated hemoglobin (A1C) Test, and Oral Glucose Tolerance Test (OGTT).
  • Based on End-User, market is studied across Diagnostic Centers, Homecare Settings, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of diabetes with increasing geriatric population
      • 5.1.1.2. Increasing trend of self-monitoring blood glucose levels at home
      • 5.1.1.3. Government initiatives and public health campaigns to address diabetes
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of diabetes diagnostic devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing adoption of point-of-care testing devices
      • 5.1.3.2. Ongoing technological advancements in diabetes diagnostics and connectivity with digital health platforms
    • 5.1.4. Challenges
      • 5.1.4.1. Device accuracy and calibration issues with diabetes diagnostic device
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Diabetes Diagnostics Market, by Diabetes Type

  • 6.1. Introduction
  • 6.2. Diabetes I
  • 6.3. Diabetes II
  • 6.4. Gestational Diabetes

7. Diabetes Diagnostics Market, by Product

  • 7.1. Introduction
  • 7.2. Biochips
  • 7.3. Glucose Monitors
  • 7.4. Kits
  • 7.5. Lancets

8. Diabetes Diagnostics Market, by Diabetes Diagnostics Type

  • 8.1. Introduction
  • 8.2. Blood Glucose Test
  • 8.3. Fasting Plasma Glucose Test
  • 8.4. Glycated hemoglobin (A1C) Test
  • 8.5. Oral Glucose Tolerance Test (OGTT)

9. Diabetes Diagnostics Market, by End-User

  • 9.1. Introduction
  • 9.2. Diagnostic Centers
  • 9.3. Homecare Settings
  • 9.4. Hospitals

10. Americas Diabetes Diagnostics Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Diabetes Diagnostics Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Diabetes Diagnostics Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3M Company
  • 2. Abbott Laboratories
  • 3. Acon Laboratories, Inc.
  • 4. AgaMatrix, Inc.
  • 5. Apex Biotechnology Corporation
  • 6. ARKRAY, Inc.
  • 7. B. Braun Melsungen AG
  • 8. Beckman Coulter, Inc.
  • 9. Becton, Dickinson and Company
  • 10. Bio-Rad Laboratories, Inc.
  • 11. Danaher Corporation
  • 12. Diabetomics, Inc.
  • 13. Diazyme Laboratories Inc
  • 14. F. Hoffmann-La Roche Ltd.
  • 15. ICON PLC
  • 16. Medtronic PLC
  • 17. Menarini Group
  • 18. Nova Biomedical Corporation
  • 19. Prestige Diagnostics
  • 20. Sanwa Kagaku Kenkyusho Co, Ltd.
  • 21. Siemens Healthineers AG
  • 22. Sinocare, Inc.
  • 23. Terumo Corporation
  • 24. Tosoh Bioscience, Inc.
  • 25. Trinity Biotech PLC

LIST OF FIGURES

  • FIGURE 1. DIABETES DIAGNOSTICS MARKET RESEARCH PROCESS
  • FIGURE 2. DIABETES DIAGNOSTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS DIABETES DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS DIABETES DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES DIABETES DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES DIABETES DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC DIABETES DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC DIABETES DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. DIABETES DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. DIABETES DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DIABETES DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DIABETES DIAGNOSTICS MARKET DYNAMICS
  • TABLE 7. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES I, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES II, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY GESTATIONAL DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY BIOCHIPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY GLUCOSE MONITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY LANCETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY BLOOD GLUCOSE TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY FASTING PLASMA GLUCOSE TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY GLYCATED HEMOGLOBIN (A1C) TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY ORAL GLUCOSE TOLERANCE TEST (OGTT), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS DIABETES DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES DIABETES DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC DIABETES DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 193. DIABETES DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 194. DIABETES DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023